[1]
2026. TO ASSESS THE EFFECTIVENESS OF FIRST-LINE XELOX COMBINED WITH BEVACIZUMAB IN PATIENTS WITH STAGE IV COLORECTAL CANCER TREATED AT NGHE AN ONCOLOGY HOSPITAL. Vietnam Journal of Community Medicine. 67, Số CĐ12- Bệnh viện Ung bướu Nghệ An (Aug. 2026). DOI:https://doi.org/10.52163/yhc.v67iCD12.6141.